Bibliographic Details
| Title: |
Molecular Determinants for Photodynamic Therapy Resistance and Improved Photosensitizer Delivery in Glioma. |
| Authors: |
Aebisher, David1 (AUTHOR) daebisher@ur.edu.pl, Woźnicki, Paweł2 (AUTHOR) pw118616@stud.ur.edu.pl, Czarnecka-Czapczyńska, Magdalena3 (AUTHOR) magdalena.czarnecka921114@gmail.com, Dynarowicz, Klaudia4 (AUTHOR) kdynarowicz@ur.edu.pl, Szliszka, Ewelina5 (AUTHOR) eszliszka@sum.edu.pl, Kawczyk-Krupka, Aleksandra3 (AUTHOR) daebisher@ur.edu.pl, Bartusik-Aebisher, Dorota6 (AUTHOR) dbartusik-aebisher@ur.edu.pl |
| Source: |
International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 16, p8708. 32p. |
| Subject Terms: |
*NEUROPEPTIDE Y receptors, *VASCULAR endothelial growth factors, *HYPOXIA-inducible factor 1, *SCIENTIFIC literature, *GENETIC profile |
| Abstract: |
Gliomas account for 24% of all the primary brain and Central Nervous System (CNS) tumors. These tumors are diverse in cellular origin, genetic profile, and morphology but collectively have one of the most dismal prognoses of all cancers. Work is constantly underway to discover a new effective form of glioma therapy. Photodynamic therapy (PDT) may be one of them. It involves the local or systemic application of a photosensitive compound—a photosensitizer (PS)—which accumulates in the affected tissues. Photosensitizer molecules absorb light of the appropriate wavelength, initiating the activation processes leading to the formation of reactive oxygen species and the selective destruction of inappropriate cells. Research focusing on the effective use of PDT in glioma therapy is already underway with promising results. In our work, we provide detailed insights into the molecular changes in glioma after photodynamic therapy. We describe a number of molecules that may contribute to the resistance of glioma cells to PDT, such as the adenosine triphosphate (ATP)-binding cassette efflux transporter G2, glutathione, ferrochelatase, heme oxygenase, and hypoxia-inducible factor 1. We identify molecular targets that can be used to improve the photosensitizer delivery to glioma cells, such as the epithelial growth factor receptor, neuropilin-1, low-density lipoprotein receptor, and neuropeptide Y receptors. We note that PDT can increase the expression of some molecules that reduce the effectiveness of therapy, such as Vascular endothelial growth factor (VEGF), glutamate, and nitric oxide. However, the scientific literature lacks clear data on the effects of PDT on many of the molecules described, and the available reports are often contradictory. In our work, we highlight the gaps in this knowledge and point to directions for further research that may enhance the efficacy of PDT in the treatment of glioma. [ABSTRACT FROM AUTHOR] |
|
Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
